<span id="midArticle_start"/>May 25 Pharming Group NV :
<span id="midArticle_0"/>* Pharming Group and Cytobioteck announce exclusivedistribution agreement for Ruconest
<span id="midArticle_1"/>* Under agreement, Cytobioteck will drive all regulatoryprocesses and will purchase its commercial supplies of Ruconestfrom Pharming at a fixed transfer price
<span id="midArticle_2"/> <span class="first-article-divide"/>* Cytobioteck will be engaged in distribution of Ruconest inColombia and Venezuela
<span id="midArticle_3"/> <span class="second-article-divide"/>* Cytobioteck S.A.S. is a privately owned Bogota, Colombiabased specialty healthcare company
<span id="midArticle_4"/> <span class="third-article-divide"/>Source text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_5"/>
<span id="midArticle_0"/>* Pharming Group and Cytobioteck announce exclusivedistribution agreement for Ruconest
<span id="midArticle_1"/>* Under agreement, Cytobioteck will drive all regulatoryprocesses and will purchase its commercial supplies of Ruconestfrom Pharming at a fixed transfer price
<span id="midArticle_2"/> <span class="first-article-divide"/>* Cytobioteck will be engaged in distribution of Ruconest inColombia and Venezuela
<span id="midArticle_3"/> <span class="second-article-divide"/>* Cytobioteck S.A.S. is a privately owned Bogota, Colombiabased specialty healthcare company
<span id="midArticle_4"/> <span class="third-article-divide"/>Source text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_5"/>
via Smart Health Shop Forum http://ift.tt/1FaFUVO
No comments:
Post a Comment